Format

Send to

Choose Destination
Nat Med. 2008 Apr;14(4):379-81. doi: 10.1038/nm1732. Epub 2008 Mar 23.

Therapeutic cloning in individual parkinsonian mice.

Author information

1
Department of Neurosurgery, Sloan-Kettering Institute, 1275 York Ave, New York, New York 10065, USA. tabarv@mskcc.org

Abstract

Cell transplantation with embryonic stem (ES) cell progeny requires immunological compatibility with host tissue. 'Therapeutic cloning' is a strategy to overcome this limitation by generating nuclear transfer (nt)ES cells that are genetically matched to an individual. Here we establish the feasibility of treating individual mice via therapeutic cloning. Derivation of 187 ntES cell lines from 24 parkinsonian mice, dopaminergic differentiation, and transplantation into individually matched host mice showed therapeutic efficacy and lack of immunological response.

PMID:
18376409
PMCID:
PMC2786166
DOI:
10.1038/nm1732
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center